Large molecule bioanalysis, immunogenicity and PK testing with higher quality data, rapid turnaround and fewer surprises.

In the competitive field of drug development where timely go/no-go decisions must be made to bring effective class-leading drugs to market, it is vital to work with a CRO that can provide highly accurate and reliable results with a quick turnaround time.  CMIC is one of the leading large molecule bioanalysis CROs providing our sponsors with:

Our Edge in Large Molecule Bioanalysis

  • A proven track record of delivering results in a timely manner.
  • A team of technical experts with a breadth of knowledge from molecular and cellular biology to analytical chemistry, covering key therapeutic areas including oncology, immuno-oncology, immunology and neurosciences.
  • Success in developing and validating the most demanding and challenging assays within specified deadlines.

Bioanalytical testing of biologics to evaluate their pharmacokinetics, pharmacodynamics, safety, and efficacy is required throughout the drug development process.   As the pipeline of biologics continues to increase, it is vital to work with a CRO whose expertise in this space can help accelerate your timeline to market.

Top Line Instruments
MSD SECTOR S 600, Gyrolab xP workstation, Thermo Fisher Quant Studio 5, BD LSRFortessa X-20, BD FACSCanto II
Molecular Device SpectraMax M4, Agilent 4200 TapeStation,

Bioanalysis and GLP Analytical Testing

Small Molecule icon

Small Molecule Bioanalysis

bioanaylysis oligonucleotides